Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis
Authors:
- Yury Y. BorshchevYBYury Y. Borshchev
- Inessa Y. BurovenkoIBInessa Y. Burovenko
- Alena B. KarasevaAKAlena B. Karaseva
- Sarkis M. MinasianSMSarkis M. Minasian
- Egor S. ProtsakEPEgor S. Protsak
- Victor Y. BorshchevVBVictor Y. Borshchev
- Natalia Y. SemenovaNSNatalia Y. Semenova
- Olga V. BorshchevaOBOlga V. Borshcheva
- Alexander N. SuvorovASAlexander N. Suvorov
- Michael M. GalagudzaMGMichael M. Galagudza
Open Access
- 18 November 2022
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 10 (11) , 2293
Abstract
In this study, we investigated the effect of three different probiotics, namely, a combination of Lactobacillus acidophilus (LA–5) and Bifidobacterium animalis subsp. lactis (BB–12), Saccharomyces boulardii, and Enterococcus faecium L3 on myocardial infarct size in rats with diet-induced obesity (DIO) and chemically-induced colitis (CIC). Potential associations between the effects of probiotics on myocardial ischemia-reperfusion injury and gut microbiome patterns as well as the serum levels of pro- and anti-inflammatory cytokines, lipopolysaccharide, and short chain fatty acids were also studied. Intragastric administration of lyophilized Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis at a dose of 1.2 × 108 CFU/mL for 15 days resulted in myocardial infarct size reduction in rats with DIO, CIC, and antibiotic-induced dysbiosis. This cardioprotective effect was associated with specific changes in cytokine concentrations, namely reduced levels of IL–1β, TNF–α, IL–2, and IL–8. At the same time, the use of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis was accompanied by a significant reduction in lipopolysaccharide level, suggesting normalization of intestinal epithelial barrier permeability. However, the cardioprotective effect of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis is not secondary to improved healing of the intestinal mucosa in CIC, as evidenced by the lack of difference in histopathological scores.Keywords
Funding Information
- Russian Science Foundation (18–15–00153)
This publication has 30 references indexed in Scilit:
- Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in RatsPLOS ONE, 2016
- TNF‐α‐induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini‐pigsJournal of Cellular and Molecular Medicine, 2014
- Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the RatCirculation: Heart Failure, 2014
- Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solutionJournal of Cardiothoracic Surgery, 2013
- Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventionsNutrition, 2013
- Intestinal microbiota determine severity of myocardial infarction in ratsThe FASEB Journal, 2012
- The Role of Comorbidities in CardioprotectionJournal of Cardiovascular Pharmacology and Therapeutics, 2011
- Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapyBasic Research in Cardiology, 2008
- TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbitsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokinesClinical and Experimental Immunology, 1998